Executive Program in Pharmaceutical Business

This opening module provides a high-level understanding of the biopharmaceutical ecosystem and its accelerating pace of innovation. Participants explore the forces that shape today’s market—from AI/ML and next-generation therapeutic modalities to evolving business models and public–private collaborations. Designed to build strategic awareness, the module equips learners with the context needed to interpret industry trends and make informed decisions across scientific, commercial, and policy domains.

• Trends
• Market dynamics
• Emerging technologies (AI/ML, gene therapy, mRNA, etc.)
• Business models
• Public-private partnerships

This module delves into the scientific and operational foundations of early-stage drug development. It examines cutting-edge biology platforms, target discovery and validation, translational approaches, and key principles in safety pharmacology. Participants gain a holistic view of the R&D continuum, understanding how scientific hypotheses are transformed into viable clinical candidates and how risk is managed during preclinical assessment.

• Biology platforms
• Target validation
• Translational science
• Safety pharmacology

Here, participants explore the critical role of biopharmaceutical manufacturing in enabling quality, scale, and patient access. The module covers process development, scale-up strategies, GMP compliance, and emerging models such as continuous and smart manufacturing. By connecting technical, operational, and regulatory perspectives, learners appreciate how manufacturing excellence underpins successful product lifecycles.

• Process development
• Scale-up
• GMPs, continuous manufacturing

This module examines how real-world data is reshaping regulatory science and post-market oversight. Participants learn how RWE informs approval decisions, labeling changes, and long-term safety monitoring. Through concrete methods and case examples, the module highlights how robust evidence generation and pharmacovigilance safeguard patient safety and strengthen clinical and commercial outcomes

• Use of real-world evidence (RWE) for regulatory purposes, and post-approval safety surveillance (methods, examples)

Participants engage with the complex landscape that determines how therapies reach patients and secure sustainable reimbursement. The module unpacks global HTA processes, payer interactions, pricing and value frameworks, and the growing importance of public and governmental affairs. By integrating policy, economics, and strategy, learners develop a comprehensive view of market access as a driver of global health impact.

• HTA processes
• Payer engagement
• Pricing frameworks
• Value-based approaches
• Global access models
• The role of public/governmental affairs in shaping market access strategies

This module focuses on the mechanics of achieving successful drug launches and sustained commercial performance. From global and local marketing strategy to digital and omnichannel engagement, participants learn how to build impactful commercial plans. The module also addresses business development, M&A, and the expanding role of patient-centricity in shaping modern commercial models.

• Commercial launch excellence
• Global/local marketing strategies
• Digital & omnichannel engagement
• Business development /M&A
• Patient-centric approaches

This module develops the interpersonal and organizational skills required to thrive in a complex, regulated, and highly cross-functional industry. Participants practice influencing without authority, managing high-performance teams, leading through uncertainty, and making sound decisions under pressure. The module strengthens leadership agility and prepares participants for senior-level responsibility.

• Influencing without authority
• Leading high-performance cross-functional teams
• Crisis leadership
• Decision-making
• Organizational agility in regulated environments

In the final component, participants form cross-functional teams to design a full end-to-end strategy for a hypothetical drug or vaccine. Guided by tutors,  teams integrate all aspects of the curriculum—science, manufacturing, evidence, access, policy, and commercialization—into a cohesive strategic plan from target identification to launch.